Second Sight Medical Products, Inc. Announces Completion of Rights Offering

SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the “Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced the completion of its rights offering, which expired at 5:00 p.m. New York time on February 15, 2019. The Company has received aggregate gross proceeds from the rights offering of approximately $34.6 mill

Full Story →